Back
DarioHealth Vs. National Research Industry Stock Comparison
Sell
17
DRIO
DarioHealth
Last Price:
0.98
Seasonality Move:
11.89%
Sell
28
NRC
National Research
Last Price:
20.00
Seasonality Move:
-0.56%
Sell
17
DarioHealth (DRIO)
is a Sell
Is DarioHealth a Buy, Sell or Hold?
- The current DarioHealth [DRIO] share price is $0.97. The Score for DRIO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- DRIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
National Research (NRC)
is a Sell
Is National Research a Buy, Sell or Hold?
- The current National Research [NRC] share price is $20.42. The Score for NRC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NRC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRIO Stock Price Chart
What is DarioHealth's stock price today?
-
The DarioHealth share price today is $0.97
The current trend is relatively stagnant and DRIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NRC Stock Price Chart
What is National Research's stock price today?
-
The National Research share price today is $20.42
The current trend is relatively stagnant and NRC is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 49.63 | Sell |
| Chaikin Money Flow: | 46986 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.94 - 1.04) | Sell |
| Bollinger Bands (100): | (0.87 - 1.17) | Sell |
NRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 59.28 | Buy |
| Chaikin Money Flow: | 51052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.21 - 19.87) | Buy |
| Bollinger Bands (100): | (19.78 - 23.96) | Sell |
DRIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Buy |
| 20-day SMA: | 0.98 | Sell |
| 50-day SMA: | 0.95 | Buy |
| 200-day SMA: | 1.33 | Sell |
| 8-day EMA: | 0.95 | Buy |
| 20-day EMA: | 0.96 | Buy |
| 50-day EMA: | 0.98 | Sell |
| 200-day EMA: | 1.38 | Sell |
NRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.6 | Buy |
| 20-day SMA: | 18.78 | Buy |
| 50-day SMA: | 20.52 | Sell |
| 200-day SMA: | 28.72 | Sell |
| 8-day EMA: | 18.93 | Buy |
| 20-day EMA: | 19.09 | Buy |
| 50-day EMA: | 20.31 | Buy |
| 200-day EMA: | 27.18 | Sell |
DarioHealth Earnings Growth & DRIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.43 per share.
National Research Earnings Growth & NRC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
DarioHealth Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
National Research Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||